Kocher, Jean-Pierre (Molecular Networks 200308– Managing Director) |
Managing Director |
Molecular Networks GmbH – Computerchemie |
Germany |
Koebernick, Marc (Siemens 202008 Head of Investor Relations at Siemens Healthineers AG) |
Public Relations Manager / Investor Relations Manager |
Siemens (Group) |
Germany |
Koehler, Udo (MGZ Munich 200709 Head of Cytogenetics) |
n. a. |
MGZ Munich (Medizinisch Genetisches Zentrum München) |
Germany |
Koehler, Uwe (Eurofins 201603 Head Gene Synthesis + Molecular Biology at Eurofins Genomics) |
President/Director/Head Business Group/Unit/Division |
Eurofins (Group) |
Germany |
Koehn, Jadranka (Rentschler 202011 Senior Direct Innovation Partnerships) |
Business Development Manager / Strategy Manager |
Rentschler (Group) |
United Kingdom (GB) |
Koenig, Alexandra (Qiagen 201902 Coordinator Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Qiagen (Group) |
Netherlands |
Koenig, Scott (MacroGenics 200109– became SVP 5/06 is CEO before MedImmune) |
Chief Executive Officer (CEO) |
MacroGenics (Group) |
United States (USA) |
Koerke, Jutta (EVES GmbH 201206 Managing Director) |
Managing Director |
EVES GmbH |
Germany |
Koeth, Sigrid (Nanogami 202409 Managing Director + SPRIND Innovation Manager) |
Managing Director |
Nanogami GmbH |
Germany |
Koga, Junichi (Daiichi Sankyo 202001 Senior Executive Officer + Global Head of RnD) |
Research & Development Manager |
Daiichi Sankyo (Group) |
Japan |
Koga, Yasukuni (Hitachi 201307 Head of Medical Systems Sales + Marketing Div of Hitachi High-Tech) |
Sales Manager / Marketing Manager |
Hitachi (Group) |
Japan |
Kogan, Dennis (Caresyntax 202408 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Caresyntax (Group) |
United States (USA) |
Kohlhaas, Jochen (Comprehensive Biomarker Center 201112– Managing Director before febit) |
Managing Director |
Hummingbird Diagnostics GmbH |
Germany |
Kohlhof, Hella (Immunic 201701– CSO before 4SC before Univ Munich) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Immunic (Group) |
Germany |
Kohrs, Arnd (IBM 201510 Sales Director DACH + CEE at Aspera) |
Sales Manager / Marketing Manager |
IBM (Group) |
France |
Kojima, Keiji (Hitachi 202010 EVP + General Manager of Smart Life Business Division) |
General Manager (management) |
Hitachi (Group) |
Japan |
Kokoris, Mark (Stratos Genomics 202005 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Kola, Ismail (UCB 201111 President of UCB New Medicines) |
President/Director/Head Business Group/Unit/Division |
UCB (Group) |
Belgium |
Kolam, Hans (Active Biotech 201208 CFO) |
Chief Financial Officer (CFO) |
Active Biotech (Group) |
Sweden |
Kolb, Daniel (Strüngmann Group 202204 Investment Manager at Athos KG) |
Investment Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Kolb, Jürgen (Priaxon AG 200903 Executive Director) |
Board member, executive |
Priaxon AG |
Germany |
Kolbe, Markus (Decodon GmbH 201303 Managing Director) |
Managing Director |
Decodon GmbH |
Germany |
Kollenberg, Henner (Glycotope 201403– Managing Director (CFO) + Eckert Life Science Acclerator before Qonsult Group) |
Managing Director |
Glycotope (Group) |
Germany |
Koller, Daniel (Bellevue Group 201409 Head of Management of BB Biotech AG) |
Investment Manager |
Bellevue (Group) |
Switzerland |
Kollmar, Martin (Goenomics 202104– Managing Director + Co-Founder) |
Managing Director |
Goenomics GmbH |
Germany |
Kolomeitsev, Alexander (ChemTaurus GmbH 201202 Managing Director) |
Managing Director |
ChemTaurus GmbH |
Germany |
Koltay, Peter (BioFluidix 201009 Managing Director) |
Sales Manager / Marketing Manager |
BioFluidix GmbH |
Germany |
Koltermann, Andre (Clariant 201308 Head Biotech + Renable Center Munich before Süd-Chemie AG + Direvo Biotech) |
President/Director/Head Business Group/Unit/Division |
Clariant (Group) |
Germany |
Kolzau, Thomas (Eppendorf 200509) |
n. a. |
Eppendorf (Group) |
Germany |
Koncar, Michael (KonValue 201810 Founder + CEO of KonValue Group + Validogen (former VTU Technology)) |
Chief Executive Officer (CEO) |
KonValue (Group) |
|
Konle, Stephanie (BRAIN 202002– Managing Associate Corporate Communications before Weka Business Medien + Merck) |
Public Relations Manager / Investor Relations Manager |
BRAIN Biotech (Group) |
Germany |
Konrad, Franz (Greiner Bio-One International AG 200810 CEO) |
Chief Executive Officer (CEO) |
Greiner (Group) |
Austria |
Konstantinides, Stavros (Univ Mainz 201406 Professor) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
Konthur, Zoltán (Drug Response Dx GmbH 201301 Managing Director) |
Managing Director |
Drug Response Dx GmbH (DRDx GmbH) |
Germany |
Koo, Eric (Overland Pharmaceuticals 202104– CEO of Overland ADCT BioPharma before Takeda China + MSC Taiwan + Bayer) |
Chief Executive Officer (CEO) |
Overland Pharmaceuticals (Group) |
China |
Koop, Hans Jochen (Leonardo Venture 2007 Managing Director) |
Managing Director |
Leonardo Venture GmbH & Co. KGaA |
Germany |
Koopman, Jaap (ProFibrix 201105– CSO before founding CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novartis (Group) |
Netherlands |
Koopman, Tim (SMS Oncology 201710 Business Developer) |
Business Development Manager / Strategy Manager |
Cato SMS (Group) |
Netherlands |
Kope, Michael (Mike) (Cyclarity 202209 CEO) |
Chief Executive Officer (CEO) |
Cyclarity Therapeutics Inc. |
United States (USA) |
Kopitzki, Fritz (CellAct Pharma 200707 Managing Director + co-founder) |
Managing Director |
CellAct Pharma GmbH |
Germany |
Kopka, Joachim (Max Planck 201210 Max Planck Institute for Molecular Plant Physiology) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
Kopp, Adolf M. (Hannoverimpuls 2014– Managing Director before TSB Innovationsagentur Berlin before BIA Bremen) |
n. a. |
Hanover (govt city) |
Germany |
Kopp, Babette (Dr. Falk Pharma 202410 Head of Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Falk Pharma (Group) |
Germany |
Koppenhöfer, Alrik (LSCN Ltd 201710 Managing Director) |
Managing Director |
LSCN Ltd. (Life Science Consulting Network) (DE) |
Germany |
Koppers, Daniel (Cunesoft GmbH 201410 Managing Director (CTO)) |
Managing Director |
Phlexglobal (Group) |
Germany |
Korf, Ansgar (mzio GmbH 202412 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
mzio GmbH |
Germany |
Korman, Hal (Mylan 201310 COO) |
Chief Operating Officer (COO) |
Viatris (Group) |
United States (USA) |
Korn, Bernhard |
n. a. |
Source BioScience (Group) |
Germany |
Korn, Lothar (Analytik Jena 201101 Managing Director AJ Blomesystem GmbH + Comicon GmbH) |
Managing Director |
GUS Group (Group) |
Germany |
Kornowski-Bonnet, Sophie (Roche 201202–201807 Head of Roche Partnering before Roche Pharma France LEFT 7/18) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
Kos, Alexander (AKos GmbH 201102 Managing Director) |
Managing Director |
AKos Consulting & Solutions Deutschland GmbH (AKos GmbH) |
Germany |
Kosaka, Tatsuro (Chugai 201301 President + COO) |
Chief Operating Officer (COO) |
Roche (Group) |
Japan |
Kosanetzky, Joseph (YXLON International 200801 CEO) |
Chief Executive Officer (CEO) |
COMET (Group) |
Germany |
Koschke, Stefan A. (AptaRes 200810) |
n. a. |
AptaRes (Group) |
Germany |
Kosijer, Dusan (Apceth 201705– CFO of Apceth Biopharma GmbH joined 10/16 before Accovion GmbH) |
Chief Financial Officer (CFO) |
Minaris Regenerative Medicine (Group) |
Germany |
Koskinen, Kalle (Genomill Health 201912 CEO) |
Chief Executive Officer (CEO) |
Genomill Health (FI) |
Finland |
Kosmecki, Bartosz (Scopis GmbH 2010– Managing Director + Founder) |
Managing Director |
Scopis GmbH |
Germany |
Koss, Ashleigh (Gilead Sciences 202402 Media Relations formerly Sanofi 202009 VP Head of Global Media Relations) |
Public Relations Manager / Investor Relations Manager |
Gilead Sciences (Group) |
United States (USA) |
Kostka, Joe (Bruker 202408 Associate Director Invesor Relations) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
Kostka, Marcus (Abalos Therapeutics 201909– Managing Director (CEO) before Boehringer Ingelheim Venture Fund) |
Chief Executive Officer (CEO) |
Abalos Therapeutics GmbH |
Germany |
Kostrzewa, Markus (Bruker 200910 Bruker Daltonik GmbH Director Molecular Biology R&D) |
Research & Development Manager |
Bruker (Group) |
Germany |
Kotsopoulos, Evangelos (Sonic Healthcare 201312 CEO of Sonic Healthcare Germany) |
Chief Executive Officer (CEO) |
Sonic Healthcare (Group) |
Germany |
Kottkamp, Eike (Pheal 202412 Managing Director + Co-Founder) |
Managing Director |
Pheal GmbH |
Germany |
Kottke, Andrea (Antisense Pharma 201207 Head Marketing + Public Relations) |
Sales Manager / Marketing Manager |
Isarna Therapeutics GmbH |
Germany |
Kottmann, Hariolf (Clariant 201102 CEO) |
Chief Executive Officer (CEO) |
Clariant (Group) |
Switzerland |
Kovács, Zoltán (Astrid Bioscience 201103– CEO + Co-founder) |
Chief Executive Officer (CEO) |
Astrid Bioscience GmbH |
Austria |
Kovalcík, Martin (i&i 202303 PR Manager) |
Public Relations Manager / Investor Relations Manager |
i&i (Group) |
Czech Republic |
Kowalski, Rob (Novartis 201803 ad interim Head of Global Drug Development + CMO) |
Chief Medical Officer (CMO) |
Novartis (Group) |
Switzerland |
Kowalski, Stanley, III (FloDesign Soncis 201910 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
Kox, Georg (Sivion Diagnostics 201011– Managing Director + Co-owner before Intelligent Venture + DASGIP) |
Managing Director |
Myriad Genetics (Group) |
Germany |
Koytiger, Greg (Immuneering 201811 SVP + Head of AI) |
n. a. |
Immuneering Corporation |
United States (USA) |
Kozlowski, Marek (NRW (govt) 202112 at NRW.Bank/Gründerfonds Ruhr) |
Investment Manager |
Nordrhein-Westfalen (govt region) |
Germany |
Kraas, Maja (IFM Therapeutics 201610 VP Operations + Site Head at IFM Therapeutics GmbH) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
Germany |
Krácala, Štepán (Grünenthal 201804 Global Head of Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Grünenthal (Group) |
Germany |
Kraemer, Matthias (Siemens 202101 at Siemens Healthineers) |
Public Relations Manager / Investor Relations Manager |
Siemens (Group) |
Germany |
Kraft, Christian (B. Braun 201810 Aesculap + CeGat + CeCaVa) |
Managing Director |
B. Braun (Group) |
Germany |
Kraft, Dieter (Trumpf 201801– Managing Director at Trumpf Venture GmbH before Robert Bosch Venture Capital GmbH) |
Managing Director |
Trumpf (Group) |
Germany |
Krafte, Doug (Icagen 201703 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Pfizer (Group) |
United States (USA) |
Kraheberger, Frank (Baden-Württemberg (govt) 202106 Head of VC Funds at MBG Baden-Württemberg) |
President/Director/Head Business Group/Unit/Division |
Baden-Württemberg (govt region) |
Germany |
Krall, Nikolaus (Allcyte 202106 CEO) |
Chief Executive Officer (CEO) |
Recursion Pharmaceuticals (Group) |
Austria |
Kramer, Ann (Oxitec 200610 Head Business Development) |
Business Development Manager / Strategy Manager |
Third Security (Randal J. Kirk) (Group) |
United Kingdom (GB) |
Kramer, Chris (Intermolecular 201905 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
Kramer, Jan (Intermed / LADR 201706 Managing Director + Owner of Intermed + LADR) |
Managing Director |
LADR / Intermed (Group) |
Germany |
Kramer, Rainer (Immatics 201204– CBO before Signature Diagnostics 201009– CBO + Jerini + MorphoSys + Amgen) |
Chief Business Officer (CBO) |
Immatics (Group) |
Germany |
Krammer, Alfred (Nanostart AG 200505 Supervisory Board) |
Board member |
BF Holding (Group) |
Germany |
Kranaster, Ramon (MyPols Biotec GmbH 201503 Managing Director) |
Managing Director |
Medix Biochemica (Group) |
Germany |
Kranenborg, Koos (Cell Signaling Technology 201306 Director Sales + Operations at BIOKÉ) |
Sales Manager / Marketing Manager |
Cell Signaling Technology (CST) (Group) |
Netherlands |
Kranner, Gerhard (Biomax Informatics 201305 CEO of Viscovery Software GmbH) |
Managing Director |
Biomax (Group) |
Austria |
Krapinger-Rüther, Bastian (1BillionLives 202410 Managing Director + Co-Founder) |
Managing Director |
1BillionLives GmbH (d/b/a Flinn) |
Austria |
Krappa, Ralf (MediGate 200602 Managing Director) |
Managing Director |
University of Hamburg |
Germany |
Krass, Peter (Trelleborg 201704 BusDev Manager Healthcare & Medical Europe Trelleborg Sealing DE) |
Business Development Manager / Strategy Manager |
Trelleborg (Group) |
Germany |
Krastins, Bryan (Thermo Fisher 201109 Group Leader at BT Center) |
Research & Development Manager |
Thermo Fisher (Group) |
United States (USA) |
Kraus, Harald (Bio-Gate AG 200603 CFO) |
Chief Financial Officer (CFO) |
Bio-Gate (Group) |
Germany |
Krause, Gérard (Helmholtz 201411 Head of Dept of Epidemiology at HZI) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Krause, Thomas (Brandenburg (govt) 202202 Managing Director of Brandenburg Kapital) |
Managing Director |
Brandenburg (govt region) |
Germany |
Kraushaar, Harald (Sony 201107 VP Business Development BioSciences at Sony DADC Austria AG) |
Business Development Manager / Strategy Manager |
Sony (Group) |
Austria |
Krauss, Martin (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
Germany |
Krauss, Ulrich (Endress+Hauser 201610–202301 CEO at Analytik Jena joined 201511 before Carl Zeiss LEFT 1/23) |
Chief Executive Officer (CEO) |
Endress+Hauser (Group) |
Germany |
Kraut, Norbert (Boehringer Ingelheim 201909 Head of Global Cancer Research) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Germany |
Krauter, Jürgen (Evonik 202003 Head of Commmunications for Nutrition + Care) |
Public Relations Manager / Investor Relations Manager |
Evonik (Group) |
Germany |